Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma
- PMID: 10515396
- DOI: 10.1034/j.1399-3003.1999.14b02.x
Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma
Comment on
-
The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma.Eur Respir J. 1999 Aug;14(2):275-82. doi: 10.1034/j.1399-3003.1999.14b07.x. Eur Respir J. 1999. PMID: 10515401 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical